Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Chronic, Non-malignant Pain”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Testing effectiveness (Phase 2)Study completedNCT00485225
What this trial is testing

Open Label, Safety Study of EN3270 in Patients With Moderate to Severe Non-malignant, Chronic Pain

Who this might be right for
Chronic, Non Malignant Pain
Durect 77
Large-scale testing (Phase 3)Study completedNCT00415597
What this trial is testing

Study of Embeda (Kadian NT, ALO-01) in Subjects With Chronic Moderate to Severe Nonmalignant Pain

Who this might be right for
Pain
Pfizer 467
Large-scale testing (Phase 3)Study completedNCT00195728
What this trial is testing

Long Term Safety and Tolerability Study in Approximately 350 Subjects With Moderate to Severe Chronic, Non-malignant Pain

Who this might be right for
Moderate to Severe Chronic, Non-malignant Pain
Abbott 431
Large-scale testing (Phase 3)Study completedNCT00347685
What this trial is testing

A One-year, Open-label Study to Assess the Safety and Effectiveness of Extended Release Tramadol HCl in the Treatment of Chronic, Non-malignant Pain.

Who this might be right for
Chronic Pain
Bausch Health Americas, Inc. 650
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT02880475
What this trial is testing

OXN PR Tablet 5/2.5 mg and20/10 mg PK Study in Chinese Moderate to Severe Chronic Non-malignant Patients

Who this might be right for
Chronic Pain
Mundipharma (China) Pharmaceutical Co. Ltd 30
Large-scale testing (Phase 3)Study completedNCT00412152
What this trial is testing

Oxycodone-naloxone in Relieving Opioid-related Constipation

Who this might be right for
Pain
Mundipharma Research GmbH & Co KG
Post-approval studies (Phase 4)Study completedNCT01961271
What this trial is testing

Evaluation Of Efficacy And Safety Of Norspan In Moderate To Severe Pain Due To Osteoarthritis, Rheumatoid Arthritis, Joint/Muscle Pain

Who this might be right for
OsteoarthritisRheumatoid ArthritisLower Back Pain+2 more
Mundipharma Pte Ltd. 114
Large-scale testing (Phase 3)Study completedNCT00412100
What this trial is testing

Oxycodone-naloxone Prolonged Release Tablets in Relieving Opioid-related Constipation

Who this might be right for
Pain
Mundipharma Research GmbH & Co KG
Large-scale testing (Phase 3)Study completedNCT01400139
What this trial is testing

Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period.

Who this might be right for
Chronic Nonmalignant and Nonneuropathic Pain
Purdue Pharma LP 922
Large-scale testing (Phase 3)Study completedNCT00902837
What this trial is testing

OXN PR Compared to OxyPR to Demonstrate Non-inferiority in Pain & Locomotor Function & Improvement in Symptoms of Constipation in OA Subjects

Who this might be right for
Chronic Osteoarthritis
Mundipharma Research GmbH & Co KG 181
Post-approval studies (Phase 4)Study completedNCT01811186
What this trial is testing

An Interventional Study to Compare the Efficacy and Tolerability With Targin® in Non-malignant Chronic Pain (GLORY)

Who this might be right for
Chronic Pain
Mundipharma Korea Ltd 261
Large-scale testing (Phase 3)Ended earlyNCT00126763
What this trial is testing

Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Non-Malignant Pain

Who this might be right for
Pain
ZARS Pharma Inc. 105
Large-scale testing (Phase 3)Study completedNCT00487435
What this trial is testing

An Open-label Extension Study With Flexible Dosing of Extended-release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic Pain

Who this might be right for
PainOsteoarthritisLow Back Pain
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1,166
Large-scale testing (Phase 3)Study completedNCT01971632
What this trial is testing

A Randomised, Double Blind, Placebo and Active Controlled, Double Dummy,Parallel Group Study to Determine the Safety and Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Subjects With Moderate to Severe, Chronic Nonmalignant Pain

Who this might be right for
Subjects With Moderate to Severe, Chronic Nonmalignant Pain
Mundipharma Research GmbH & Co KG 463
Testing effectiveness (Phase 2)Ended earlyNCT00278824
What this trial is testing

Fentanyl Transdermal Patch With CHADD™ for Breakthrough Pain in Patients With Moderate to Severe Non-Malignant Pain

Who this might be right for
Pain
ZARS Pharma Inc. 109